本文選題：鹽酸右美托咪定 + 帕瑞昔布鈉　； 參考：《吉林大學(xué)》2017年碩士論文

【摘要】：目的:觀察單獨應(yīng)用鹽酸右美托咪定和帕瑞昔布鈉或二者聯(lián)合應(yīng)用在開腹胃腸手術(shù)的療效,并評估其對患者圍術(shù)期的影響。方法:選取2015年3月至2016年12月于吉林大學(xué)中日聯(lián)誼醫(yī)院新民院區(qū)普通外科住院全麻下行開腹胃腸手術(shù)患者80例。ASA I-III級,年齡40-70歲,體重45-80kg,全部患者隨機分成四組,每組患者數(shù)量20。常規(guī)全麻誘導(dǎo)后,經(jīng)口明視氣管插管,控制呼吸。術(shù)中靜吸復(fù)合麻醉,維持BIS值40-60之間。A組:對照組(n=20),誘導(dǎo)前15min,20ml0.9%NaCl溶液,0.7ml/min持續(xù)泵注30min。手術(shù)結(jié)束前30min,2ml0.9%NaCl溶液靜推。B組:鹽酸右美托咪定組(n=20),誘導(dǎo)前15min,鹽酸右美托咪定0.6ug/kg負(fù)荷量溶于20ml 0.9%NaCl溶液,0.7ml/min持續(xù)泵注30min。手術(shù)結(jié)束前30min,2ml 0.9%NaCl溶液靜推。C組:帕瑞昔布鈉組(n=20),誘導(dǎo)前15min,20ml 0.9%NaCl溶液,0.7ml/min持續(xù)泵注30min。手術(shù)結(jié)束前30min,40mg帕瑞昔布鈉溶于2ml 0.9%NaCl溶液靜推。D組:聯(lián)合組(n=20),誘導(dǎo)前15min,鹽酸右美托咪定0.6ug/kg負(fù)荷量溶于20ml 0.9%NaCl溶液,0.7ml/min持續(xù)泵注30min。手術(shù)結(jié)束前30min,40mg帕瑞昔布鈉溶于2ml 0.9%NaCl溶液靜推。手術(shù)結(jié)束后連接啟動相同配比的靜脈自控鎮(zhèn)痛泵(PCIA)。觀察并記錄四組患者蘇醒時間(停麻藥到睜眼的時間);拔管時間(停麻藥到拔管的時間);手術(shù)時間;術(shù)中出血量及尿量;泵藥前5min(T0),泵藥后5min(T1),插管后1min(T2),切皮時(T3),拔管時(T4),五個時刻心率(HR)、平均動脈壓(MAP);術(shù)后1h(t1),2h(t2),4h(t3),6h(t4),12h(t5),24h(t6),48h(t7)的疼痛及鎮(zhèn)靜情況(VAS評分及Ramsay鎮(zhèn)靜評分);自控鎮(zhèn)痛泵按壓次數(shù);術(shù)后惡心、嘔吐、頭暈、躁動、皮膚瘙癢、呼吸抑制、吻合口漏、術(shù)后出血例數(shù)。結(jié)果:(1)比較四組患者的性別、年齡、體重、蘇醒時間、拔管時間、手術(shù)時間、術(shù)中出血量、術(shù)中尿量,無明顯差異(P0.05)。(2)心血管反應(yīng):四組患者T0時刻HR、MAP無顯著差異(P0.05)。與T0相比,T1時,輸注右美托咪定的B、D組,HR下降明顯(P0.05),MAP無明顯變化(P0.05)。T2時,四組患者HR、MAP均有上升趨勢,但未輸注右美托咪定的A、C組HR、MAP上升幅度更明顯(P0.05),輸注右美托咪定的B、D組HR、MAP波動幅度輕微,差異無統(tǒng)計學(xué)意義(P0.05);T4時,四組患者HR、MAP上升,但未給予帕瑞昔布鈉的A、B組HR、MAP上升幅度更明顯(P0.05)。(3)術(shù)后靜止及活動狀態(tài)時疼痛評估(VAS評分)及鎮(zhèn)靜評分(Ramsay鎮(zhèn)靜評分):與A組相比,B、C、D組患者VAS評分顯著降低(P0.01)。與B、C組患者相比,D組患者VAS評分降幅更明顯(P0.05)。與A、C組患者相比,B、D組鎮(zhèn)靜評分高(P0.05)。(4)PCIA按壓次數(shù):與A組相比,B、C、D組患者按壓次數(shù)較少(P0.05)。與B、C組相比,D組患者按壓次數(shù)更少(P0.01)。(5)術(shù)后不良反應(yīng):與A組患者相比,B、C、D組患者術(shù)后躁動的發(fā)生例數(shù)明顯降低(P0.05)。與B、C組患者相比,D組患者發(fā)生術(shù)后躁動例數(shù)更少。四組患者其他不良反應(yīng)發(fā)生率無明顯差異(P0.05)。結(jié)論:1.開腹胃腸手術(shù)圍術(shù)期無論是單獨應(yīng)用鹽酸右美托咪定和帕瑞昔布鈉,還是兩者聯(lián)合應(yīng)用均可以減緩患者術(shù)后疼痛,減少PCIA用量。2聯(lián)合應(yīng)用鹽酸右美托咪定和帕瑞昔布鈉,手術(shù)過程血流動力學(xué)更平穩(wěn),PCIA用量更少,鎮(zhèn)痛效果更好,不良反應(yīng)更少,患者滿意度更高。
[Abstract]:Objective: To observe the effect of combined application of dexmeimidine hydrochloride and pareoxib sodium or two groups in laparotomy for gastrointestinal surgery and evaluate its effect on perioperative period. Methods: from March 2015 to December 2016, 80 cases of gastroenteric surgery under general general anesthesia under general general anesthesia under general general anesthesia in the new folk Hospital of Jilin University Sino Japan Friendship Hospital were selected. .ASA I-III, age 40-70, and weight 45-80kg, all the patients were randomly divided into four groups. The number of patients in each group was 20. with general anesthesia induction, the tracheal intubation and control of respiration were carried out. The BIS value 40-60 was maintained in the.A group: the control group (n=20), before induction, 15min, 20ml0.9%NaCl solution, and 0.7ml/min sustained pump 30min. operation ended. Anterior 30min, 2ml0.9%NaCl solution statically push.B group: right metoimidin group (n=20), pre induced 15min, dexmedetomidin 0.6ug/kg load in 20ml 0.9%NaCl solution, 0.7ml/min continuous pumping 30min. before the end of the operation. 30min, 40mg parinoxib sodium dissolved in 2ml 0.9%NaCl solution in group.D before the end of 30min. operation: Joint Group (n=20), pre induced 15min, right metomomidine 0.6ug/kg load in 20ml 0.9%NaCl solution, 0.7ml/min continued before the end of the operation. Connecting the intravenous self controlled analgesia pump (PCIA) with the same proportion, observed and recorded four groups of patients' awakening time (the time of stopping the medicine to the eyes open), the time of extubation (the time of stopping the anesthetic to the extubation), the time of the operation, the amount of bleeding and the amount of urine in the operation, the 5min (T0) before the pump, the 5min (T1) after the pump, the 1min (T2) after the intubation, the T3), the extubation (T4), and the extubation (T4), and five moments. Heart rate (HR), mean arterial pressure (MAP); postoperative 1H (T1), 2h (T2), 4H (T3), 6h (T4), 12h (T5), analgesic pump press times; postoperative nausea, vomiting, dizziness, restlessness, skin itching, respiratory depression, anastomotic leakage, postoperative bleeding cases. Results: (1) compared four groups of patients. Sex, age, weight, time of extubation, operation time, intraoperative bleeding, and urine volume were not significantly different (P0.05). (2) cardiovascular response: there was no significant difference between the four groups of patients at time HR and MAP (P0.05). When compared with T0, T1, the B of right metoimidin, D group, HR decreased significantly (P0.05), and four groups of patients had no obvious changes. AP had an upward trend, but the A of right metodetomidine, C group HR, MAP increased significantly (P0.05), B in right metoimidin, HR in group D, MAP in D, and MAP fluctuated slightly, and the difference was not statistically significant (P0.05). Pain assessment (VAS score) and sedation score (Ramsay sedation score): compared with group A, VAS scores in group B, C and D were significantly lower (P0.01). Compared with B, C group, D group was significantly lower. (4) Less pressure (P0.05). Compared with B, group C, group D patients had less press times (P0.01). (5) postoperative adverse reaction: compared with group A, the number of postoperative restlessness in B, C, and D group was significantly lower (P0.05). Compared with B, C group, patients with postoperative restlessness were less. There was no significant difference in the incidence of other adverse reactions between the four groups. 05). Conclusion: 1. in the perioperative period of laparotomy, both dexmeimidine hydrochloride and pareoxib sodium, or both, can reduce postoperative pain and reduce the amount of PCIA,.2 combined with dexmeimidin and pareoxib sodium, the operation process is more stable, PCIA is less, and the analgesic effect is more effective. Well, less adverse reactions and higher patient satisfaction.

【學(xué)位授予單位】：吉林大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R614

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 譚玲,何艷,尤桂萍;老年人胃腸手術(shù)的護理體會[J];職業(yè)衛(wèi)生與病傷;2003年01期

2 崔玉君，劉紅;外科胃腸手術(shù)后的飲食[J];青海醫(yī)藥雜志;1996年07期

3 彭俊生,詹文華;胃腸手術(shù)的引流問題[J];中國實用外科雜志;1998年04期

4 詹文華,彭俊生;胃腸手術(shù)的引流應(yīng)用[J];臨床外科雜志;2000年06期

5 孫海燕,姜梅,于新文;胃腸手術(shù)后飲食指導(dǎo)[J];中國鄉(xiāng)村醫(yī)藥;2000年11期

6 劉麗萍,李偉,鮑淑芝;胃腸手術(shù)后的飲食及護理[J];航空航天醫(yī)藥;2001年04期

7 欒永秋;;胃腸手術(shù)后階段飲食的護理[J];長春中醫(yī)學(xué)院學(xué)報;2005年04期

8 陳志美;茍麗;曾俊;;一次性切口層保護器在胃腸手術(shù)中的應(yīng)用[J];中國實用護理雜志;2006年29期

9 常艷;陳燕;季愛華;;用熱敷巧治胃腸手術(shù)患者突發(fā)感冒[J];中國實用醫(yī)藥;2012年17期

10 吳敏;包木仁;;胃腸手術(shù)后并發(fā)腸瘺30例臨床研究[J];中國醫(yī)藥指南;2013年22期

相關(guān)會議論文 前5條

1 馬純雪;徐曉瓊;戴曉琴;;胃腸手術(shù)腸內(nèi)營養(yǎng)的護理觀察[A];2013年浙江省腸外腸內(nèi)營養(yǎng)學(xué)學(xué)術(shù)年會論文匯編[C];2013年

2 趙雅莉;樊錦平;;腦科粘貼手術(shù)膜在胃腸手術(shù)中的巧用[A];創(chuàng)建患者安全文化——中華護理學(xué)會第15屆全國手術(shù)室護理學(xué)術(shù)交流會議論文匯編（下冊）[C];2011年

3 周麗娟;;胃腸手術(shù)過程中保護性無菌隔離措施及配合[A];河南省手術(shù)室護理學(xué)術(shù)交流暨高級研修班資料匯編[C];2007年

4 唐鳳元;;中老年患者胃腸手術(shù)圍手術(shù)期肺部感染的預(yù)見性護理[A];全國外科、神經(jīng)內(nèi)外科護理學(xué)術(shù)交流暨專題講座會議論文匯編[C];2006年

5 蔡北源;李建華;何宜斌;;腹部胃腸手術(shù)后的辨證論治體會[A];中國中西醫(yī)結(jié)合學(xué)會圍手術(shù)期專業(yè)委員會成立大會暨第二屆全國中西醫(yī)結(jié)合圍手術(shù)期醫(yī)學(xué)專題研討會論文集[C];2007年

相關(guān)重要報紙文章 前2條

1 海翔;胃腸手術(shù)后病人要暫停牛奶[N];大眾衛(wèi)生報;2004年

2 胡云華;胃腸手術(shù)部份切除者應(yīng)如何進(jìn)食[N];云南科技報;2002年

相關(guān)碩士學(xué)位論文 前4條

1 陳鏡伊;地塞米松對老年胃腸手術(shù)患者術(shù)后早期認(rèn)知功能及相關(guān)生物標(biāo)志物的影響[D];中國人民解放軍醫(yī)學(xué)院;2015年

2 趙璽;中藥促進(jìn)氣機壅滯證非胃腸手術(shù)后患者胃腸功能恢復(fù)的療效觀察[D];北京中醫(yī)藥大學(xué);2017年

3 段學(xué)姣;鹽酸右美托咪定聯(lián)合帕瑞昔布鈉在開腹胃腸手術(shù)患者圍術(shù)期療效觀察[D];吉林大學(xué);2017年

4 藍(lán)旭;快針針刺足三里對腹部非胃腸手術(shù)患者術(shù)后胃腸功能恢復(fù)的影響[D];北京中醫(yī)藥大學(xué);2014年

，

本文編號：1783236